Teriparatide
( DrugBank: Teriparatide / KEGG DRUG: Teriparatide acetate, Teriparatide, Teriparatide acetate )
7 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
| 68 | Ossification of the ligamentum flavum | 1 |
| 70 | Spinal stenosis | 4 |
| 71 | Idiopathic osteonecrosis of the femoral head | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 172 | Hypophosphatasia | 1 |
| 235 | Hypoparathyroidism | 17 |
| 274 | Osteogenesis Imperfecta | 7 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,543 / Drugs : 2,251 - (DrugBank : 390) / Drug target genes : 198 - Drug target pathways : 232
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
68. Ossification of the ligamentum flavum
Clinical trial : 1 / Drugs : 3 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 4
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
70. Spinal stenosis
Clinical trials : 127 / Drugs : 178 - (DrugBank : 67) / Drug target genes : 87 - Drug target pathways : 99
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
71. Idiopathic osteonecrosis of the femoral head
Clinical trials : 2 / Drugs : 3 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 7
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
172. Hypophosphatasia
Clinical trials : 44 / Drugs : 29 - (DrugBank : 8) / Drug target genes : 7 - Drug target pathways : 17
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
235. Hypoparathyroidism
Clinical trials : 100 / Drugs : 103 - (DrugBank : 27) / Drug target genes : 5 - Drug target pathways : 7
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
274. Osteogenesis Imperfecta
Clinical trials : 102 / Drugs : 82 - (DrugBank : 22) / Drug target genes : 15 - Drug target pathways : 79
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|